Estudo randomizado | Mais dados mostram que a azitromicina não é melhor que placebo em pacientes com Covid-19.

Effect of Oral Azithromycin vs Placebo on COVID-19 Symptoms in Outpatients With SARS-CoV-2 Infection: A Randomized Clinical Trial – JAMA

Comentário: Common antibiotic no more effective than placebo in preventing COVID-19 symptoms among non-hospitalized – University of California – San Francisco

Relacionado: RCT: Another study shows Azithromycin does not improve outcomes in patients with Covid-19. (vários artigos sobre o assunto)

Comentário no Twitter

Among outpatients with #SARSCoV2 infection, treatment with a single dose of oral #azithromycin compared with placebo did not result in a greater likelihood of being free of symptoms at day 14 https://t.co/dYDcSyGtwd #COVID19

— JAMA (@JAMA_current) July 16, 2021